ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1872

Gout in Older Adult

Mara McAdams-DeMarco1, Anna Kottgen2, Bridget Burke3, Andrew Law4, Josef Coresh1 and Alan N. Baer5, 1Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2Renal Division, University Hospital Freiburg, Freiburg, Germany, 3Johns Hopkins University, Baltimore, MD, 4Epidemiology, Johns Hopkins, Baltimore, MD, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Aging, Genetic Biomarkers and gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health III: Gout and Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: To evaluate whether traditional and genetic risk factors in middle-aged members of a longitudinal population-based cohort predict the onset of gout in older age.

Methods: We studied the incidence and prevalence of gout in white older adults using the Atherosclerosis Risk in Communities Study, a prospective US population-based cohort study of middle-aged adults enrolled between 1987-1989 with ongoing follow-up. A genetic urate score (GUS) was formed from common urate-associated single nucleotide polymorphisms for eight genes. The adjusted hazard ratio (HR) and 95% confidence intervals (CI) of incident gout by traditional and genetic risk factors in middle age were estimated using a Cox Proportional Hazards model.

Results: Of the 9,526 participants, 46.2% were male and the mean (SD) age at cohort enrollment was 54.0 (5.7). The overall prevalence of gout was 8.9%; 31.9% of those with a history of gout reported a physician diagnosis of this inflammatory arthritis at age 65 or older. By age 65 the prevalence of gout was 9.0% for men and 3.3% for women, conditioned on survival to age 65. The cumulative incidence from middle age to age 65 was 8.6% in men and 2.5% in women as well as 8.0% for those in the 4th quartile of GUS, 5.0% for those in the 3rd quartile, 3.8% for those in the 2nd quartile and 3.3% for those in the 1st quartile, conditioned on survival to age 65 (Figure). In middle age, increased adiposity, beer intake, protein intake, smoking status, hypertension, diuretic use, and kidney function (but not sex) were associated with an increased risk of gout in older age. In addition, high genetic risk (100 μmol/L increase in GUS) was associated with a 3.29-fold (95% CI: 1.63, 6.63) increased risk of gout in older age.

Conclusion: In this US population-based cohort, traditional risk factors that were present in middle-age were associated with the development of gout in older age.

Figure: Cumulative incidence of gout by quartile of genetic urate score. The incidence of gout for participants of ARIC was estimated using a Kaplan-Meier approach. All cumulative incidences (%) should be interpreted as the percentage of participants with gout, conditioned on survival to that age. The genetic urate score is measured in μmol/L. Quartile 1 of the genetic urate score ranges from -59.1 to -13.1; quartile 2 from -13.2 to 0.3; quartile 3 from -.4 to 12.0 and quartile 4 from 12.1 to 60.8.


Disclosure:

M. McAdams-DeMarco,
None;

A. Kottgen,
None;

B. Burke,
None;

A. Law,
None;

J. Coresh,
None;

A. N. Baer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gout-in-older-adult/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology